Phocas Financial’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-99,589
Closed -$2.42M – 98
2026
Q2
$2.42M Buy
+99,589
New +$1.7M 0.34% 111

Other funds holding NRIX

Phocas Financial's NRIX Position: Q3 2026 in Review

Phocas Financial sold out of Nurix Therapeutics (NRIX) in Q3 2026, closing a stake of 99,589 shares — an estimated $2.42M sold.

Phocas Financial first reported a position in NRIX in Q2 2026 and held it in 1 quarter. The position peaked at $2.42M in Q2 2026. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Phocas Financial reported no remaining Nurix Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial sold 99,589 Nurix Therapeutics shares in Q3 2026, an estimated $2.42M.
  • Phocas Financial first reported a position in Nurix Therapeutics in Q2 2026 and held it in 1 quarter.
  • Phocas Financial's Nurix Therapeutics position peaked at $2.42M in Q2 2026.
  • 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Phocas Financial's 13F filing for Q3 2026.